Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NXP Semiconductors
NXPI
US Stock MarketDetailed Quotes
Orchestra BioMed (OBIO)
- 3.800
- -0.060-1.55%
Close Jul 29 16:00 ET
- 3.800
- 0.0000.00%
Post 19:34 ET
227.55MMarket Cap-4.00P/E (TTM)
3.950High3.780Low256.02KVolume3.850Open3.860Prev Close992.89KTurnover0.78%Turnover RatioLossP/E (Static)59.88MShares5.42452wk High5.52P/B124.48MFloat Cap2.20052wk Low--Dividend TTM32.76MShs Float23.390Historical High--Div Yield TTM4.40%Range %2.200Historical Low3.878Avg Price1Lot Size
OBIO Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
OBIO Orderflow
Unit: --
OBIO Orderflow Trend
IntradayDayWeekMonth
No Data
Orchestra BioMed (OBIO) News
Orchestra BioMed Joins Russell 3000, Russell 2000 Indexes
Express News | Orchestra Biomed Joins Russell 3000® and Russell 2000® Indexes
Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes
Health Care Had the Best Week Vs. the S&P 500 on Record
Orchestra BioMed Shareholders Approve Directors and Incentive Plan
Orchestra BioMed Holdings (OBIO) Gets a Hold From BTIG
Orchestra BioMed (OBIO) Stock Forum
$Orchestra BioMed (OBIO.US)$ Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
1 minutes ago, 8:01 AM EDT
Via GlobeNewswire
$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, bringing total capital received from Ligand to $40 million to date in exchange for tiered royalty interest in Orchestra BioMed's future revenue as well as equity
Funding supports continued execution of Orch...
1 minutes ago, 8:01 AM EDT
Via GlobeNewswire
$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, bringing total capital received from Ligand to $40 million to date in exchange for tiered royalty interest in Orchestra BioMed's future revenue as well as equity
Funding supports continued execution of Orch...
$Orchestra BioMed (OBIO.US)$ Reuters
1m
Orchestra Biomed Receives $20 Million Payment From Medtronic Under Previously Announced Financing Agreement
1m
Orchestra Biomed Receives $20 Million Payment From Medtronic Under Previously Announced Financing Agreement
$Orchestra BioMed (OBIO.US)$
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
by Globe Newswire
Follow
Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial ("BACKBEAT Trial") evaluating Atrioventricular Interval Modulation Therapy ("AVIM Therapy") in patients with uncontrolled hypertension and an indication for a pacemaker as part of the strate...
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
by Globe Newswire
Follow
Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial ("BACKBEAT Trial") evaluating Atrioventricular Interval Modulation Therapy ("AVIM Therapy") in patients with uncontrolled hypertension and an indication for a pacemaker as part of the strate...
$Orchestra BioMed (OBIO.US)$ Reuters
just
Orchestra Biomed Announces Avim Therapy and Virtue SAB Program Presentations at Ici Meeting
just
Orchestra Biomed Announces Avim Therapy and Virtue SAB Program Presentations at Ici Meeting
1
Read more
Market Insights
Hot AI Stocks Hot AI Stocks
AI stocks surge on chip demand and cloud security breakthroughs; future growth hinges on autonomous driving and global computing infrastructure AI stocks surge on chip demand and cloud security breakthroughs; future growth hinges on autonomous driving and global computing infrastructure